Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy

Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial

(2018) Kazuyuki Suzuki et al.   HEPATOLOGY RESEARCH

The animal naming test: An easy tool for the assessment of hepatic encephalopathy

(2017) Francesca Campagna et al.   HEPATOLOGY

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

(2017) Jasmohan S. Bajaj et al.   HEPATOLOGY

The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy

(2017) Daniela Viramontes Hörner et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Gut microbiome and liver disease

(2017) Naga S. Betrapally et al.   Translational Research

Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation

(2017) Lili Sheng et al.   Scientific Reports

Probiotics and prebiotics in Crohn's disease therapies

(2016) Lev Lichtenstein et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Probiotics and prebiotics in ulcerative colitis

(2016) Lauranne A.A.P. Derikx et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Microbe-host interactions: Influence of the gut microbiota on the enteric nervous system

(2016) Niall P. Hyland et al.   DEVELOPMENTAL BIOLOGY

Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice

(2016) Dae Joong Kang et al.   HEPATOLOGY

Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis

(2016) Lise L. Gluud et al.   HEPATOLOGY

Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy

(2016) Alba Moratalla et al.   LIVER INTERNATIONAL

Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides

(2016) Marsha Y. Morgan   METABOLIC BRAIN DISEASE

Probiotics in management of hepatic encephalopathy

(2016) Barjesh Chander Sharma et al.   METABOLIC BRAIN DISEASE

Ammonia toxicity: from head to toe?

(2016) Srinivasan Dasarathy et al.   METABOLIC BRAIN DISEASE

Neurotoxicity of Ammonia

(2016) Simo S. Oja et al.   NEUROCHEMICAL RESEARCH

Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis

(2016) Peggy P. Ho et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia

(2016) Don Rockey et al.   SEMINARS IN LIVER DISEASE

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis

(2016) Vishwadeep Ahluwalia et al.   Scientific Reports

Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition

(2016) Dae J Kang et al.   Clinical and Translational Gastroenterology

Gut microbiota and metabolic syndrome

(2016) Davide Festi et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Serotonin, tryptophan metabolism and the brain-gut-microbiome axis

(2015) S.M. O’Mahony et al.   BEHAVIOURAL BRAIN RESEARCH

Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health

(2015) Robert A. Rastall et al.   CURRENT OPINION IN BIOTECHNOLOGY

Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut

(2015) Jason M. Ridlon et al.   DIGESTIVE DISEASES

Gut–Liver Axis in Alcoholic Liver Disease

(2015) Gyongyi Szabo   GASTROENTEROLOGY

Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease

(2015) M Llopis et al.   GUT

Fecal microbiota transplantation in the management of hepatic encephalopathy

(2015) Dina Kao et al.   HEPATOLOGY

Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy

(2015) Jasmohan S. Bajaj et al.   HEPATOLOGY

Probiotics in Pediatric Liver Disease

(2015) Tamir Miloh   JOURNAL OF CLINICAL GASTROENTEROLOGY

Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials

(2015) Sammy Saab et al.   LIVER INTERNATIONAL

Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases

(2015) Herbert L. DuPont   MAYO CLINIC PROCEEDINGS

Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited

(2015) Roger F. Butterworth   METABOLIC BRAIN DISEASE

Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy

(2015) Yan-yong Liu et al.   Neural Regeneration Research

Gut microbiota and host metabolism in liver cirrhosis

(2015) Makoto Usami   WORLD JOURNAL OF GASTROENTEROLOGY

Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis

(2015) Li-Na Zhao et al.   Clinics and Research in Hepatology and Gastroenterology

Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children

(2015) S. Guandalini et al.   Beneficial Microbes

Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease

(2015) Jerome Boursier et al.   PLoS Pathogens

Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver

(2015) Mayuka Nakajima et al.   PLoS One

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

(2014) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy

(2014) N. Kimer et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis

(2014) J. S. Bajaj et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality

(2014) N. J. Taylor et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Altered brain-gut axis in autism: Comorbidity or causative mechanisms?

(2014) Emeran A. Mayer et al.   BIOESSAYS

Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial

(2014) Radha K. Dhiman et al.   GASTROENTEROLOGY

Interactions Between the Intestinal Microbiome and Liver Diseases

(2014) Bernd Schnabl et al.   GASTROENTEROLOGY

Randomised controlled trial of lactulose versus rifaximin for prophylaxis of hepatic encephalopathy in patients with acute variceal bleed

(2014) Sudhir Maharshi et al.   GUT

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

(2014) Hendrik Vilstrup et al.   HEPATOLOGY

Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial

(2014) Venigalla Pratap Mouli et al.   HEPATOLOGY RESEARCH

The Gut Microbiome and the Brain

(2014) Leo Galland   JOURNAL OF MEDICINAL FOOD

Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites

(2014) Diego Rincón et al.   LIVER INTERNATIONAL

VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis

(2014) Elisabet Sánchez et al.   LIVER INTERNATIONAL

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

(2014) Colin Hill et al.   Nature Reviews Gastroenterology & Hepatology

Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System

(2014) Sherzad K. Rashid et al.   PLoS One

Immune dysfunction in cirrhosis

(2014) Nora Sipeki   WORLD JOURNAL OF GASTROENTEROLOGY

Microbiota and the gut-liver axis: Bacterial translocation, inflammation and infection in cirrhosis

(2014) Valerio Giannelli   WORLD JOURNAL OF GASTROENTEROLOGY

Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice

(2014) Chiara Degirolamo et al.   Cell Reports

Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry

(2014) Eva M Selhub et al.   Journal of Physiological Anthropology

Sensitization of Peripheral Sensory Nerves by Mediators From Colonic Biopsies of Diarrhea-Predominant Irritable Bowel Syndrome Patients: A Role for PAR2

(2013) Eduardo E Valdez-Morales et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy

(2013) Barjesh Chander Sharma et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Immune Activation in Irritable Bowel Syndrome: Can Neuroimmune Interactions Explain Symptoms?

(2013) Patrick A Hughes et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Large-Scale Survey of Gut Microbiota Associated With MHE Via 16S rRNA-Based Pyrosequencing

(2013) Zhigang Zhang et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration

(2013) Hanqin Lei et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition

(2013) Javier Vaquero et al.   BIOCHEMICAL PHARMACOLOGY

Psychobiotics: A Novel Class of Psychotropic

(2013) Timothy G. Dinan et al.   BIOLOGICAL PSYCHIATRY

The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury

(2013) Bing Chang et al.   BMC GASTROENTEROLOGY

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

(2013) Maitreyi Raman et al.   Clinical Gastroenterology and Hepatology

Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial

(2013) Manish Kumar Lunia et al.   Clinical Gastroenterology and Hepatology

Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy

(2013) Kevin D. Mullen et al.   Clinical Gastroenterology and Hepatology

The gut-liver axis

(2013) Ruben G.J. Visschers et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Gut microbiota, enteroendocrine functions and metabolism

(2013) Patrice D Cani et al.   CURRENT OPINION IN PHARMACOLOGY

Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy

(2013) Lokesh Jain et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Modulation of the fecal bile acid profile by gut microbiota in cirrhosis

(2013) Genta Kakiyama et al.   JOURNAL OF HEPATOLOGY

Pathological bacterial translocation in liver cirrhosis

(2013) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Altered profile of human gut microbiome is associated with cirrhosis and its complications

(2013) Jasmohan S. Bajaj et al.   JOURNAL OF HEPATOLOGY

Microbiome Composition by Pyrosequencing in Mesenteric Lymph Nodes of Rats with CCl4-Induced Cirrhosis

(2013) Silvia Cuenca et al.   Journal of Innate Immunity

Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial

(2013) Nitin Gupta et al.   LIVER INTERNATIONAL

Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: A realistic hope?

(2013) M. Sonal Sekhar et al.   MEDICAL HYPOTHESES

Gut microbiota and hepatic encephalopathy

(2013) Radha K. Dhiman   METABOLIC BRAIN DISEASE

Antibiotics for the treatment of hepatic encephalopathy

(2013) Kavish R. Patidar et al.   METABOLIC BRAIN DISEASE

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

(2013) Yukihiro Furusawa et al.   NATURE

Altered colonic function and microbiota profile in a mouse model of chronic depression

(2013) A. J. Park et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

(2013) Jasmohan S. Bajaj et al.   PLoS One

Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome

(2012) J. Matricon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Voices from within: gut microbes and the CNS

(2012) Paul Forsythe et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy

(2012) C F Rose   CLINICAL PHARMACOLOGY & THERAPEUTICS

Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure

(2012) Cristina R. Bosoi et al.   FREE RADICAL BIOLOGY AND MEDICINE

Intestinal microbiota in functional bowel disorders: a Rome foundation report

(2012) Magnus Simrén et al.   GUT

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

(2012) Lixin Zhu et al.   HEPATOLOGY

Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy

(2012) Kathrine Holte et al.   HEPATOLOGY RESEARCH

The chemical interactome space between the human host and the genetically defined gut metabotypes

(2012) Ulrik Plesner Jacobsen et al.   ISME Journal

Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: An open labeled randomized controlled trial of lactulose versus no lactulose

(2012) Praveen Sharma et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease

(2012) Derrick E. Fouts et al.   JOURNAL OF HEPATOLOGY

The gut microbiota and the liver. Pathophysiological and clinical implications

(2012) Eamonn M.M. Quigley et al.   JOURNAL OF HEPATOLOGY

Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications

(2012) Pablo Bellot et al.   LIVER INTERNATIONAL

A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy

(2012) Jasmohan S. Bajaj et al.   METABOLIC BRAIN DISEASE

Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10 −/− mice

(2012) Suzanne Devkota et al.   NATURE

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

(2012) Jorge Henao-Mejia et al.   NATURE

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

(2012) John F. Cryan et al.   NATURE REVIEWS NEUROSCIENCE

Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axis

(2012) Peter Holzer et al.   NEUROPEPTIDES

Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease

(2012) D. Compare et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Role of the intestinal microbiome in health and disease: from correlation to causation

(2012) Willem M de Vos et al.   NUTRITION REVIEWS

Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology

(2012) Timothy G. Dinan et al.   PSYCHONEUROENDOCRINOLOGY

Rifaximinvsconventional oral therapy for hepatic encephalopathy: A meta-analysis

(2012) Karim M Eltawil   WORLD JOURNAL OF GASTROENTEROLOGY

Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy

(2011) S. Shukla et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading

(2011) Thijs W.H. Pols et al.   Cell Metabolism

Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy

(2011) Ming Luo et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

(2011) Vibhu Vibhas Mittal et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Biologic properties and clinical uses of rifaximin

(2011) Herbert L DuPont   EXPERT OPINION ON PHARMACOTHERAPY

Characterization of fecal microbial communities in patients with liver cirrhosis

(2011) Yanfei Chen et al.   HEPATOLOGY

Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output

(2011) Anna Baghdasaryan et al.   HEPATOLOGY

Intestinal bacterial translocation in rats with cirrhosis is related to compromised paneth cell antimicrobial host defense

(2011) Zora Teltschik et al.   HEPATOLOGY

Gut Microbiota, Intestinal Permeability, Obesity-Induced Inflammation, and Liver Injury

(2011) Thomas H. Frazier et al.   JOURNAL OF PARENTERAL AND ENTERAL NUTRITION

Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection

(2011) Haifeng Lu et al.   MICROBIAL ECOLOGY

Gut feelings: the emerging biology of gut–brain communication

(2011) Emeran A. Mayer   NATURE REVIEWS NEUROSCIENCE

Investigating the biological and clinical significance of human dysbioses

(2011) Daniel N. Frank et al.   TRENDS IN MICROBIOLOGY

Gut Microbiota and Inflammation

(2011) Asa Hakansson et al.   Nutrients

Peripheral and Splanchnic Indole and Oxindole Levels in Cirrhotic Patients: A Study on the Pathophysiology of Hepatic Encephalopathy

(2010) Oliviero Riggio et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal

(2010) Jan Albrecht et al.   BIOCHEMICAL PHARMACOLOGY

Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections

(2010) Manuela Merli et al.   Clinical Gastroenterology and Hepatology

Pharmacotherapy for Hepatic Encephalopathy

(2010) Paula V. Phongsamran et al.   DRUGS

Effects of intestinal intervention on bacterial translocation in a rat model of acute liver failure in vivo

(2010) Jie Yang et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study

(2010) Ulrich Thalheimer et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Hepatic encephalopathy

(2010) Michael Bismuth et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis

(2010) Philip A. Berry et al.   INTENSIVE CARE MEDICINE

Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy

(2010) Ankur Gupta et al.   JOURNAL OF HEPATOLOGY

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

(2010) Thijs W.H. Pols et al.   JOURNAL OF HEPATOLOGY

Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis

(2010) D.L. Shawcross et al.   JOURNAL OF HEPATOLOGY

Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis

(2010) Christian J Steib et al.   LABORATORY INVESTIGATION

Interorgan ammonia metabolism in liver failure: the basis of current and future therapies

(2010) Gavin Wright et al.   LIVER INTERNATIONAL

Rifaximin Treatment in Hepatic Encephalopathy

(2010) Nathan M. Bass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins

(2010) P. J. Turnbaugh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

(2010) J. R. Swann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

(2010) C. De Filippo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Gut Feeling about GABA: Focus on GABAB Receptors

(2010) Niall P. Hyland et al.   Frontiers in Pharmacology

Intestinal Permeability in Cirrhotic Patients With and Without Spontaneous Bacterial Peritonitis: Is the Ring Closed?

(2009) Emidio Scarpellini et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage

(2009) Rita Cariello et al.   DIGESTIVE AND LIVER DISEASE

Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults

(2009) Mirjana Rajilić-Stojanović et al.   ENVIRONMENTAL MICROBIOLOGY

L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats

(2009) Nathan A. Davies et al.   HEPATOLOGY

Microbial endocrinology as a basis for improved l-DOPA bioavailability in Parkinson’s patients treated for Helicobacter pylori

(2009) Mark Lyte   MEDICAL HYPOTHESES

Principles and clinical implications of the brain–gut–enteric microbiota axis

(2009) Sang H. Rhee et al.   Nature Reviews Gastroenterology & Hepatology

MR Imaging Findings in Hepatic Encephalopathy

(2008) A. Rovira et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Ammonia impairs neutrophil phagocytic function in liver disease

(2008) Debbie L. Shawcross et al.   HEPATOLOGY

Identifying the direct effects of ammonia on the brain

(2008) Cristina R. Bosoi et al.   METABOLIC BRAIN DISEASE

A core gut microbiome in obese and lean twins

(2008) Peter J. Turnbaugh et al.   NATURE

Commensal microbiota is fundamental for the development of inflammatory pain

(2008) F. A. Amaral et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

(2008) H. Sokol et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

(2008) B. S. Samuel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Symbiotic gut microbes modulate human metabolic phenotypes

(2008) M. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA